Current filters:


Popular Filters

1980 to 2004 of 2379 results

Merck KGaA collaborates with Dr Reddy's on biosimilars


With the aim of capitalizing on the batch of patent expires for blockbuster biotechnology-based drugs…

BiotechnologyDr Reddy's LaboratoriesGenericsMarkets & MarketingMerck KGaAMerck SeronoOncologyResearch

KYTHERA Biopharma gets $33.3 million in payments from Bayer


Privately-held US biotech firm KYTHERA Biopharmaceuticals says it has received a $15.8 million payment…

BayerBiotechnologyFinancialKYTHERA BiopharmaceuticalsLicensingPharmaceuticalResearch

Reimbursement outlook for DMT Alzheimer's therapies in Europe


Emerging potentially disease-modifying therapies (DMTs) for Alzheimer's disease will likely be reimbursed…

BiotechnologyEuropeMarkets & MarketingNeurologicalPharmaceuticalPricing

UK pharma industry head fears for future of UK medical research


The UK government is too focused on encouraging "breakthrough drugs" at the expense of significant gains…


Enterologics aims to produce Rx biotherapeutics for GI diseases


USA-based biotech firm Enterologics (OTCBB: ELGO.OB), which is focussed on the development of live biotherapeutic…

BiotechnologyEnterologicsGastro-intestinalsNorth AmericaResearch

Zacks analysts view progress of GSK bid for Human Genome Sciences


UK pharma giant GlaxoSmithKline (LSE: GSK) recently announced that the waiting period with respect to…

BenlystaBiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Onyx Pharma links with Texas MD Anderson Cancer Center on research


US biotech firm Onyx Pharmaceuticals (Nasdaq: ONXX) and The University of Texas MD Anderson Cancer Center…

BiotechnologycarfilzomibOncologyOnyx PharmaceuticalsoprozomibResearch

Rindopepimut likely to be Rxed by 36% of surveyed US oncologists for GMB patients


US oncologists surveyed by advisory firm Decision Resources indicate that they would prescribe the emerging…

BiotechnologyCelldex TherapeuticsMarkets & MarketingNorth AmericaOncologyPharmaceuticalrindopepimut

NicOx drops its option to take full ownership of Altacor


French biotechnology firm NicOx (NYSE Euronext Paris: COX) said last Friday that its board of directors…

AltacorBiotechnologyMergers & AcquisitionsNicOxOphthalmics

EMA boosts EU transparency with on-line publication of suspected side effect reports


The European Medicines Agency yesterday began publishing suspected side effect reports for medicines…


Alnylam's RSV drug candidate misses primary endpoint in Ph IIb


Leading USA-based RNAi therapeutics firm Alnylam Pharmaceuticals (Nasdaq: ALNY) yesterday announced disappointing…

Alnylam PharmaceuticalsBiotechnologyResearchRespiratory and Pulmonary

BioAlliance's Sitavig NDA "receivable" by US FDA


French biotech firm BioAlliance Pharma (Euronext Paris: BIO) has announced the receivability of its Sitavig…

Anti-viralsBioAlliance PharmaBiotechnologyNorth AmericaRegulationSitavigSitavir

Expanded Access Program for enzalutamide agreed with US FDA


The US Food and Drug Administration agreed that Medivation (Nasdaq: MDVN) and Japanese drug major Astellas…

Astellas PharmaBiotechnologyenzalutamideMDV3100MedivationNorth AmericaOncologyPharmaceuticalRegulation

US legislation could block public access to drug safety information, claim consumer groups


A provision in the Food and Drug Administration Reform Act that would block public access to potentially…

BiotechnologyNorth AmericaPharmaceuticalPoliticsRegulation

Genentech links up with Ensemble Thera for macrocyclic drug candidates discovery


Swiss drug major Roche's (ROG: SIX) subsidiary Genentech has initiated a drug discovery collaboration…

BiotechnologyEnsemble TherapeuticsGenentechLicensingResearchRoche

Rainbow BioSci seeks to develop treatment for traumatic brain injury


USA-based Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp (OTCBB: RBCC) revealed yesterday…

Amarantus BioSciencesBiotechnologyLicensingNeurologicalRainbow Biosciences

UK health and life sciences group agrees new clinical trials transparency principles


The Ethical Standards in Health and Life Sciences Group (ESHLSG), a partnership including the Association…


EMA orphan drug committee makes 16 recommendations at May meeting


The European Medicines Agency's Committee for Orphan Medicinal Products (COMP) adopted a total of 16…

Alexion PharmaceuticalsBiotechnologyeculizumabEuropePharmaceuticalRare diseasesRegulation

1980 to 2004 of 2379 results

Back to top